RankingsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Revenue

Mochida Pharmaceutical Co.,Ltd.【JP:4534】

Market cap
¥131.5B
P/E ratio
23.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 2025105,159+2.21%
Mar 31, 2024102,885-0.36%
Mar 31, 2023103,261-6.28%
Mar 31, 2022110,179+6.98%
Mar 31, 2021102,995+1.17%
Mar 31, 2020101,799-7.15%
Mar 31, 2019109,643+2.70%
Mar 31, 2018106,761+9.67%
Mar 31, 201797,349+5.50%
Mar 31, 201692,272+5.75%
Mar 31, 201587,252-7.13%
Mar 31, 201493,947+5.31%
Mar 31, 201389,210+3.49%
Mar 31, 201286,205

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)